Correction of murine PKU following AAV-mediated intramuscular expression of a complete phenylalanine hydroxylating system

被引:52
作者
Ding, Zhaobing [1 ]
Harding, Cary O. [2 ,3 ]
Rebuffat, Alexandre [1 ]
Elzaouk, Lina [1 ]
Wolff, Jon A. [4 ,5 ]
Thoeny, Beat [1 ]
机构
[1] Univ Zurich, Dept Pediat, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland
[2] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA
[4] Univ Wisconsin, Dept Pediat, Waisman Ctr, Madison, WI USA
[5] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA
关键词
D O I
10.1038/mt.2008.17
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Phenylketonuria (PKU) caused by phenylalanine hydroxylase (PAH) deficiency leads to toxic accumulation of phenylalanine (Phe). PAH is predominantly expressed in liver and its activity requires a supply of tetrahydrobiopterin (BH4) cofactor, but we propose that expression of a complete Phe hydroxylating system (PAH plus BH4 synthetic enzymes) in skeletal muscle will lead to therapeutic reduction of blood Phe levels in Pah(enu2) mice, a model of human PKU. In order to test this hypothesis, we first developed transgenic Pahenu2 mice that lack liver PAH activity but coexpress, in their skeletal muscle, PAH and guanosine triphosphate cyclohydrolase I (GTPCH). The latter is responsible for the committing enzymatic step in BH4 biosynthesis. Despite sufficient muscle enzyme expression, these mice remained hyperphenylalaninemic, thereby suggesting that expression of additional BH4 synthetic enzymes would be necessary. A recombinant triple-cistronic adeno-associated virus-2 (AAV2) pseudotype 1 vector expressing PAH along with GTPCH and 6-pyruvoyltetrahydrobiopterin synthase (PTPS), the next step in BH4 synthesis, was generated. Injection of this vector into the gastrocnemius muscles of Pah(enu2) mice led to stable and long-term reduction of blood Phe and reversal of PKU-associated coat hypopigmentation. We propose that muscle-directed gene therapy will be a viable alternative treatment approach to PKU and other inborn errors of metabolism.
引用
收藏
页码:673 / 681
页数:9
相关论文
共 49 条
[21]   Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus [J].
Herzog, RW ;
Hagstrom, JN ;
Kung, SH ;
Tai, SJ ;
Wilson, JM ;
Fisher, KJ ;
High, KA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (11) :5804-5809
[22]   No evidence for germ-tine transmission following prenatal and early postnatal AAV-mediated gene delivery [J].
Jakob, M ;
Mühle, C ;
Park, J ;
Weiss, S ;
Waddington, S ;
Schneider, H .
JOURNAL OF GENE MEDICINE, 2005, 7 (05) :630-637
[23]   THE MUSCLE CREATINE-KINASE GENE IS REGULATED BY MULTIPLE UPSTREAM ELEMENTS, INCLUDING A MUSCLE-SPECIFIC ENHANCER [J].
JAYNES, JB ;
JOHNSON, JE ;
BUSKIN, JN ;
GARTSIDE, CL ;
HAUSCHKA, SD .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (01) :62-70
[24]   Long-term correction of hyperbilirubinemia in the Gunn rat by repeated intravenous delivery of naked plasmid DNA into muscle [J].
Jia, Z ;
Dankó, I .
MOLECULAR THERAPY, 2005, 12 (05) :860-866
[25]  
Laufs S, 2000, J GENE MED, V2, P22, DOI 10.1002/(SICI)1521-2254(200001/02)2:1<22::AID-JGM86>3.0.CO
[26]  
2-1
[27]  
LEDLEY FD, 1987, J BIOL CHEM, V262, P2228
[28]  
Levy HL, 1996, TERATOLOGY, V53, P176
[29]  
Loser P, 1998, J VIROL, V72, P180
[30]   Gene transfer into skeletal muscle using novel AAV serotypes [J].
Louboutin, JP ;
Wang, LL ;
Wilson, JM .
JOURNAL OF GENE MEDICINE, 2005, 7 (04) :442-451